logo

For the Inventor, By the Inventor

Narita, Japan

Kinichi Mogi

This inventor holds 12 USPTO granted patents. Top assignees: Ss Pharmaceutical Co., Ltd., Ssp Co. Ltd. Active years: 1984-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kinichi Mogi. Retrieved from https://idiyas.com/inventor/kinichi-mogi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Abiko, JP (1984 - 1990)
  • Chiba, JP (1996 - 1999)
  • Narita, JP (1993 - 2002)

Company Filing History:

goldMedal9 out of 90 
 
Ss Pharmaceutical Co., Ltd.
 patents
silverMedal3 out of 27 
 
Ssp Co. Ltd
 patents

Years Active: 1984-2002

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6362203 - 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same (2002-03-26),
2. 6028081 - Substituted quinolone derivatives and pharmaceuticals containing the same (2000-02-22),
3. 5962509 - Dithiolylidene acetamide derivatives (1999-10-05),
4. 5902826 - Platinum (IV) complex and pharmaceutical composition comprising the same (1999-05-11),
5. 5585511 - Platinum complex and malignant tumor treating drug containing the same (1996-12-17),
6. 5498780 - Platinum complex and malignant tumor treating drug containing the same (1996-03-12),
7. 5231101 - Benzo[5,6]cyclohepta[1,2-B]pyridine derivatives and antiallergic agents (1993-07-27),
8. 4977275 - Pyrrole derivatives (1990-12-11),
9. 4968825 - Novel platinum complex (1990-11-06),
10. 4904809 - Platinum complex (1990-02-27),
11. 4548753 - 2,3-Butanediol diester derivatives (1985-10-22),
12. 4469704 - 2,3-Butanediol diester derivatives, process for producing the same, and (1984-09-04),

Title: Kinichi Mogi: Innovator in Pharmaceutical Chemistry

Introduction

Kinichi Mogi is a prominent inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 12 patents to his name, Mogi has established himself as a key figure in the development of new pharmaceutical compounds.

Latest Patents

Mogi's latest patents include groundbreaking work on 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same. He has also developed substituted quinolone derivatives and pharmaceuticals that exhibit excellent anti-ulcer activities. These derivatives are represented by specific chemical formulas, showcasing Mogi's expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Mogi has worked with notable companies such as Ss Pharmaceutical Co., Ltd. and Ssp Co., Ltd. His work has been instrumental in advancing pharmaceutical research and development, leading to the creation of innovative products that address various medical needs.

Collaborations

Mogi has collaborated with esteemed colleagues, including Susumu Sato and Hiroyuki Mizuno. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical chemistry.

Conclusion

Kinichi Mogi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…